Our key topics  

Rentschler Biopharma Icon climate protection

Climate protection

Resource efficiency and waste prevention

Energy efficiency

Our goals 

CO2 emissions

Goal: To reduce our absolute Scope 1 & 2 emissions by 37.8% by the end of 2029 from a 2023 base year.

In the fiscal year 2024/2025, our Scope 1 and 2 emissions experienced a slight increase of 2%, primarily due to one-off factors. We remain fully committed and are intensifying our efforts to meet our climate target by 2029.

Recycling rate

Goal: Increase the separate collection rate to over 50% by 2030.

At our Laupheim site, we aim to raise our separate collection rate to more than 50% by 2030. In the 2024/2025 fiscal year, we successfully increased this rate by 4 percentage points, reaching 40%. 

Energy efficiency

Goal: 1% improvement per year, measured as energy consumption per batch per fiscal year

At our Laupheim facility, we are committed to continuously improving energy efficiency. In the 2024/2025 fiscal year, we succeeded in reducing energy consumption per batch produced by 11.2% compared to the previous year.

Validated climate targets by the SBTi

Climate protection is a core pillar of our sustainability strategy. To reinforce our commitment, we have successfully had our climate target validated by the Science Based Targets initiative (SBTi). We are dedicated to contributing to the achievement of the 1.5°C goal by reducing our Scope 1 and 2 emissions by 37.8% by 2029 compared to a 2023 base year. Additionally, 82% of our suppliers (by emissions) are expected to have science-based climate targets by 2029.
Our validated climate target is available for review on the SBTi homepage.

SCIENCE BASED TARGETS

Our corporate carbon footprint

To effectively manage and reduce our GHG emissions, we monitor our Scope 1 and 2 emissions on a monthly basis, enabling us to promptly address any deviations from our targets.

Additionally, we calculate our complete Corporate Carbon Footprint (CCF) once a year, which takes into account not only the emissions from our own business operations and energy consumption, but also those from the value chain (Scope 3).

For the 2024/2025 fiscal year, our CCF has been officially verified by TÜV Nord, ensuring that our calculation methods meet the rigorous standards set by the GHG Protocol.

ISO 50001 certification for energy efficiency

Our new energy management system (EnMS) at the Laupheim site obtained ISO 50001 certification.

This globally recognized certification confirms our commitment to energy efficiency as well as compliance with legal and regulatory requirements through organizational, technical and staff-related measures.

Its implementation not only promotes best practices in energy management but also increases energy efficiency, benefiting both the environment and cost reduction.

 

Rentschler Biopharma ISO 50001 Team and certification

Core elements of our climate and energy management

Procurement of green electricity 

Learn More

Since January 1, 2024, our Laupheim facility has been powered exclusively by certified green electricity (through EACs).











Energy efficiency measures

Learn More

Through a wide range of energy efficiency measures and investments in more energy-efficient infrastructure, we are continuously reducing our energy consumption.

Measurement infrastructure

Learn More

By continuously expanding our metering infrastructure for the most significant energy consumers, we are able to measure and manage energy consumption in a targeted manner.

Get in touch

Do you have any questions or suggestions about sustainability at Rentschler Biopharma?

*Required Fields